We compared the diagnostic and prognostic utility of phospholipase A (PLA; EC 3.1.1.4) for acute pancreatitis with that of amylase and lipase by analysis of sera from 151 consecutive patients presenting with abdominal pain in whom assays of serum amylase and (or) lipase had been ordered. We determined the diagnostic accuracy for both the initial and the peak enzyme activities. Maximal diagnostic accuracy obtained for the initial activities of amylase, lipase, and PLA was 0.83, 0.83, and 0.76 at cutoff valuesof650,650,and 41 U/L,respectively. Use of peak enzyme activities showed maximal diagnostic accuracy of 0.85, 0.86, and 0.73 at cutoff values of 650, 1050, and 42 U/L,respectively. Receiver-operator characteristic curve analysis revealed the diagnostic performance of amylaseand lipase tobe similar, whereas that of PLA was almostrandom and not incremental. As with amylase and lipase,PLA activities in sera showed no relation to patients' survival; three patients who died after an attack of acute pancreatitis failed to demonstrate the dramatic increases in PLA activity previously described. We conclude that assessing the severity of acute pancreatitis by using enzyme activities still remains problematical. Measurements of amylase or lipase activities provide similar diagnostic discrimination when appropriate cutoff values areused and remain the methods of choice for diagnosis of acute pancreatitis.
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The enzyme diagnosis of pancreatic injury is usually accomplished by measurement of amylase (1,4-alpha-Dglucan glucanohydrolase; EC 3.2.1.1) and (or) lipase (triacyiglycerol acylhydrolase; EC 3.1.1.3) activities in serum. Release of phospholipase A (PLA; lecithinase A, phosphatide 2-acylhydrolase; EC 3.1.1.4) by injured pancreas tissue has been suggested to play an important role in the pathogenesis of acute pancreatitis and may facilitate the diagnosis of this disease (1, 2) . In contrast to amylase and lipase, activity of PLA in serum has also been advocatedas a marker of the severity of pancreatitis, with greatly increased activities of PLA being associated with severe hemorrhagic forms of the disease and lesser increases being found in the mild edematous type (1, 3) .
Recently Procedures. Total amylase and lipase activities in serum were measured in a Cobas-Fara centrifugal analyzer (Roche Diagnostic Systems, Nutley, NJ 07110). The assay for amylase, based on a coupled enzymatic reaction sequence with maltotetraose as substrate, was performed according to the manufacturer's protocol (Roche Diagnostic Systems). Lipase activities in serum were measured by monitoring the rate of decrease in the turbidity of a triolein suspension (Boehringer Mannheim Diagnostics, Indianapolis, IN 46250). We measured PLA activities according to the method of Hoffmann et al. (8, 9) . The assay is based on the liberation of long-chain fatty acids from an emulsion of soybean phosphatidylcholine.
The initial part of the assayrequires a manual timed incubation. In brief, the patient's serum is added to two tubes containing reagent with phosphatidylcholine substrate prewarmed to 37#{176}C. The tubes are immediately placed in a 37#{176}C shaking water bath.After 5 mm of incubation, stop reagent (EDTA, 6 mmol/L in 0.05 molfL phosphate buffer, pH 5.5) is added to one of the tubes, which serves as the blank. After an additional 60-mm incubation, stop reagent is added to the remaining tube. The difference in free fatty acid concentrations in the two tubes is proportional to PLA activity. The concentration of free fatty acids formed by the action of PLA on phosphatidylcholine is determined by use of an enzymatic procedure we adapted to the Cobas-Fara analyzer ( Table 1 lists the centrifugal analyzer settings for this assay). One unit (1 U) of PLA activity was defined as that amount of enzyme liberating 1 pmol of free fatty acids per minute at 37#{176}C. Analytical imprecision is relatively high because of the low absorbance changes involved. Therefore, we assayed patients' samples in duplicate and used the mean value.
We determined the linearity and precision of our automated PLA method as described in NCCLS guidelines EP6 (10) and EP5 (11), respectively.
The upper limits of the reference interval for amylase and lipase activities in clinical use are 135 and 190 U/L, respectively. The reference interval for PLA activity in serum was determined by analysis of serum samples from 25 men and 25 women who underwent routine health examination and appeared to be in good health.
We compared means by Student's t-test, and determined reference intervals by using the REF'VAL protocol (12) . We compared reference value groups by the MannWhitney U-test. The 95% confidence limit was used to assess statistical significance.
Results
The semiautomated procedure for PLA exhibited a linear response with increasing enzyme activity up to 92 UIL. Samples with activity exceeding this range gave the expected values after dilution. The lower detection limit of the automated method was evaluated by analysis of replicate reagent blanks. The enzyme activity corresponding to an absorbance change that exceeded by 3SD the mean absorbance change of reagent alone was 2.18 U/L.
The precision of the amylase, lipase, and PLA procedures was evaluated by analyzing two separate pools of patients' sera with normal and increased enzyme activities. The patients' serum pools were aliquoted into individual tubes, stored frozen at -20 #{176}C, and analyzed in duplicate aliquots, once daily for 20 consecutive days. Table 2 summarizes the results of the precision studies.
PLA activity was measured in serum from 50 apparently normal individuals. The central 95 percentile interval was 7.3-9.7 UIL by nonparametric analysis. Analysis of the data by the Mann-Whitney U-test revealed no significant gender-related differences.
We used the final discharge diagnosis to classify patients into one of two groups. Group I comprised 42 patients with clinically or surgically documented pancreatitis; Group II comprised 109 control patients without pancreatitis. Fifty-one of the patients had had tests performed on an inpatient basis; the other 100 patients had had tests performed after presentation to the Emergency Department. Ten (20%) of the inpatients and 32 (32%) of those who presented to the Emergency Department were found to have experienced an attack of acute pancreatitis. Thirty-one (74%) of the patients with pancreatitis and 57 (52%) of the control patients had their diagnoses confirmed by sonogram, computerized tomography, or laparoscopy.
Peak activities of amylase and lipase in serum of patients with acute pancreatitis were significantly correlated (r = 0.56, P <0.05). Peak PLA and amylase activities correlated poorly (r = 0.08, P >0.10), as did peak PLA and lipase activities (r = 0.12, P >0.10).
The temporal change in PLA activity in patients with lipase. The time [mean (SD)] from onset of pain to peak PLA activity was 62 (31) h vs 50 (26) and 58 (26) h for amylase and lipase, respectively. The mean peak activities of PLA were significantly greater (P <0.05) in patients with acute pancreatitis than in the control patients, but there was substantial overlap between both groups (Table 3) . PLA activities were >30 UIL in 11 (26%) patients with acute pancreatitis, but >50 U/L in only three. These three patients had experienced acute abdominal pain for three or four days before seeking medical attention. The significance of greatly increased PLA activities in patients with acute pancreatitis who delay in seeking treatment is unclear. The highest PLA activity was observed in a patientwho had experienced acute abdominal pain for threeconsecutive days after consuming a substantial quantity of ethanol. His serum PLA and lipase activities were significantly increased at the initial presentation: 109 and 1520 UIL, respectively; his amylase activity was mildly increased, 263 U/L. This patient's hospital course was unremarkable and he was discharged 10 days later.
In 13 (12%) of the control patients, PLA activities exceeded 30 UIL. Five of these patients were noted to have some form of gastrointestinal disturbance, including gastritis and perforate and imperforate gastric ulcer. The highest PLA activity seen in a control patient was 53 UIL in an individual with massive head trauma after a motor vehicle accident. The association of head trauma and extremely increased PLA activities has also been previously reported (13).
We did not find PLA activities in serum to be an indicator of patients' survival. A total of 13 (9%) patients died during the course of this study, three after an attack of acute pancreatitis. PLA activities in these three patients, measured within 48 h of death, were <15 UIL. Of the 10 nonsurvivors in the control group, one patient with a perforated gastric ulcer demonstrated PLA activities of 34 UIL before death. The remaining nine patients showed PLA activities <25 UIL in the last sample taken.
The diagnostic efficiency of each enzyme was assessed by use of ROC curves derived from initial enzyme findings obtained when the physician first ordered amylase or lipase because of suspected pancreatitis, and from peak enzyme activities retrospectively obtained from patients with two or more serial enzyme measurements (Figure 1) . For 30 patients, all in the control group, enzyme activities were determined only once. Based on the initial enzyme activities, the maximal diagnostic accuracy (efficiency) achieved by adjustment of the diagnostic cutoff value was 0.83, 0.83, and 0.76 for amylase, lipase, and PLA at cutoff values of 650, 650, and 41 UIL, respectively. Use of peak enzyme activities revealed similar diagnostic accuracy. The diagnostic accuracies obtained with use of peak enzyme activities were 0.85,0.86, and 0.73 for amylase, lipase, and PLA at cutoff values of 650, 1050, and 42 UIL, respectively. The sensitivities and specificities associated with each diagnostic cutoff value are shown in Table 4 . The ROC curves clearly demonstrate that the diagnostic performance of PLA for acute pancreatitis is almost random and not incremental.
Discussion
The recent development of a semiautomated assay for PLA activity has stimulated investigations of the utility of PLA as a diagnostic and prognostic marker for acute pancreatitis (8, 9) . Previous methods for measurement ofPLA activity were both labor intensive and expensive (14, 15) . As a result, the number of patients included in these studies was often small. We have shown that an inexpensive, semiautomated assay for PLA can be readily adapted for routine laboratory use with the Cobas-Faracentrifugal analyzer.
We assessed the diagnostic performance of amylase, lipase, and PLA for acute pancreatitis.
Many evaluations of diagnostic markers for acute pancreatitis are deficient with respect to preselection of patient populations. Our patient population consisted of individuals who had amylase or lipase ordered by a physician because of suspected pancreatitis. Thus, we evaluated ainylase, lipase, and PLA in the appropriate clinical context in which these markers are used for thediagnosis of acute pancreatitis. We also evaluated the diagnostic performance of each enzyme by use of initial and peak enzyme activities. The use of peak enzyme activities selected retrospectively from serial measurements for the evaluation of the diagnostic capabilities of markers for acute pancreatitis is unrealistic; the immediate diagnosis of a life-threatening event, such as acute pancreatitis, forces the physician to rely on initial enzyme findings. The precision, linearity, and analytical sensitivity of our assay were comparable with that of the previously reported assay (8, 9) . The total precision of the assay varied with PLA activity. The imprecision in samples with PLA activities <10 U/L was relatively high. Duplicate analysis of all specimens is probably warranted.
The upper reference interval for PLA activity in sera of normal men and women (9.7 UIL) was essentially identical to that previously reported (10 U/L) for a similar semiautomated method (9). We did not find PLA useful for diagnosing acute pancreatitis.
Values were also markedly increased in a wide variety of conditions not involving the pancreas.
Although PLA may contribute to the necrosis and auto- Although others have reported an increase in mortality associated with increasing PLA activities in serum (13, 19, 20) , we could not confirm such findings. Patients who died after an attack of acute pancreatitis had PLA activities well below those values seen in patients with mild, uncomplicated cases of acute pancreatitis. We conclude that assessment of the severity of acute pancreatitis by using PLA activities is not possible.
Determination of lipase activity with use of colipase supplementation has been advocated as an efficient predictor of pancreatitis (21, 22 PTA activities in serum show no correlation with patients' survival and are therefore of no help in assessing prognosis. Assays of amylase or lipase provide similar diagnostic discrimination when appropriate cutoff values are used and remain the methods of choice for the diagnosis of acute pancreatitis.
